Which basal insulin should be used for a 70‑kg adult?

Basal Insulin Selection for a 70-kg Adult

For a 70-kg adult requiring basal insulin, use insulin glargine U-100, insulin detemir, insulin degludec, or insulin glargine U-300 as first-line options, with the specific choice guided by hypoglycemia risk and weight concerns. 1, 2

Initial Dosing Strategy

Start with 10 units daily or 0.1-0.2 units/kg/day (7-14 units for a 70-kg patient), depending on the clinical scenario 3, 2:

• Use 0.1-0.2 units/kg/day (7-14 units) for:

  • Insulin-naïve patients
  • Age ≥70 years
  • Renal impairment (GFR <60 mL/min)
  • Risk of hypoglycemia 4

• Use 0.3-0.4 units/kg/day (21-28 units) for:

  • Blood glucose 140-200 mg/dL
  • No high-risk features 4, 1

• Use 0.5 units/kg/day (35 units) for:

  • Blood glucose 201-400 mg/dL
  • No contraindications 4

Choosing the Specific Basal Insulin

The 2021 Lancet Diabetes & Endocrinology guidelines and 2024 network meta-analysis provide clear differentiation 1, 5:

When Hypoglycemia is the Primary Concern:

Use insulin degludec (100 or 200 U/mL), insulin glargine U-300, or insulin detemir over NPH insulin. These newer analogs reduce nocturnal and overall hypoglycemia risk by 4-6 fold compared to NPH 1, 5. Degludec and glargine U-300 show lower nocturnal hypoglycemia rates than glargine U-100 2, 5.

When Weight Gain is the Primary Concern:

Insulin glargine U-300 is associated with 2.9-4.1 kg less weight gain compared to other basal insulins (degludec, detemir, NPH) 5. This makes it the preferred choice when weight is a critical consideration.

For Cost-Conscious Situations:

NPH insulin remains an option but carries significantly higher hypoglycemia risk. Long-acting analogs (glargine U-100, detemir) provide better safety profiles and should be prioritized when feasible 3, 2.

Practical Administration

• Once-daily dosing: Glargine U-100, glargine U-300, degludec (can be given at any consistent time)
• Once or twice-daily dosing: Detemir, NPH (typically require twice-daily dosing for 24-hour coverage) 4, 3

For hospitalized patients, give basal insulin in the morning rather than bedtime to simplify management 4, 6, 7.

Titration Approach

Adjust dose based on fasting blood glucose over 3-7 days 3, 2, 8:

• Increase by 2 units if fasting glucose consistently above target (typically 80-130 mg/dL)
• Decrease by 2 units if fasting glucose <80 mg/dL on ≥2 occasions per week
• Continue metformin and consider other non-insulin agents during titration 3

Critical Threshold: Avoiding Overbasalization

Do not exceed 0.5 units/kg/day (35 units for 70-kg patient) without reassessing the treatment plan 2, 9. Doses above this threshold show diminishing glycemic benefit with increased weight gain and no additional hypoglycemia reduction 9. At this point, consider:

1. Adding a GLP-1 receptor agonist (preferred) 2
2. Adding prandial insulin at the largest meal 3, 2
3. Switching to more concentrated preparations if volume is an issue 3

Common Pitfalls to Avoid

Never use sliding-scale insulin alone in patients with established diabetes—it results in worse glycemic control and 3-fold increased hyperglycemia risk 4, 1. Avoid premixed insulin (70/30) in most settings due to unacceptably high hypoglycemia rates 1.

For patients already on home insulin ≥0.6 units/kg/day, reduce total daily dose by 20% when hospitalized to prevent hypoglycemia from reduced oral intake 1.

The evidence strongly supports long-acting basal analogs over NPH for superior safety profiles, though all basal insulins demonstrate comparable efficacy in HbA1c reduction 5. The choice ultimately depends on balancing hypoglycemia risk, weight concerns, and cost considerations for the individual patient.